Trial Profile
Tesetaxel in heavily pretreated patients with advanced breast cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 05 Aug 2021
Price :
$35
*
At a glance
- Drugs Tesetaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Nov 2010 New trial record